Concepedia

M K Yunmbam

MK

Statistics

Publications

8

Citations

340

H-Index

8

Active since

1992

Affiliations

National Cancer Institute(Current)

National Institutes of Health

North Carolina State University

Georgetown University

M K Yunmbam is an author at National Cancer Institute specializing in oncology, medicine, and cancer pharmacology.

Publications per year

1992–2001

8

Publications

8

Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells.

Q. Li, Jingjing Yu, M K Yunmbam et al. · PubMed · 2000 · 162 citations

, , +11

Prevention of cisplatin–DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors

Edward G. Mimnaugh, M K Yunmbam, Qingdi Li et al. · Biochemical Pharmacology · 2000 · 54 citations

, , +17

Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer.

John L. Marshall, Anton Wellstein, James M. Rae et al. · PubMed · 1997 · 36 citations

, , +13

Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression.

Qingdi Q. Li, M K Yunmbam, Xu Zhong et al. · PubMed · 2001 · 31 citations

, , +15

Effect of the proteasome inhibitor ALLnL on cisplatin sensitivity in human ovarian tumor cells

M K Yunmbam, Qingdi Li, Edward G. Mimnaugh et al. · International Journal of Oncology · 2001 · 21 citations

, , +13

1–5 of 8